A whole-body dual-modality radionuclide-optical strategy for pre-clinical imaging of metastasis and heterogeneous treatment response in different microenvironments

gan Fruhwirth, Gilbert O., Diocou, Seckou, Blower, Philip J., Ng, Tony, Mullen, Greg
Cyhoeddwyd yn J Nucl Med (2014)

(68)Ga-THP-PSMA: a PET imaging agent for prostate cancer offering rapid, room temperature, one-step kit-based radiolabeling

gan Young, Jennifer D., Abbate, Vincenzo, Imberti, Cinzia, Meszaros, Levente K., Ma, Michelle T., Terry, Samantha Y. A., Hider, Robert C., Mullen, Greg E., Blower, Philip J.
Cyhoeddwyd yn J Nucl Med (2017)

HER2 Mediates PSMA/mGluR1-Driven Resistance to the DS-7423 Dual PI3K/mTOR Inhibitor in PTEN Wild-type Prostate Cancer Models

gan Gómez, Valentí, Galazi, Myria, Weitsman, Gregory, Monypenny, James, Al-Salemee, Fahad, Barber, Paul R., Ng, Kenrick, Beatson, Richard, Szokol, Bálint, Orfi, László, Mullen, Greg, Vanhaesebroeck, Bart, Chowdhury, Simon, Leung, Hing Y., Ng, Tony
Cyhoeddwyd yn Mol Cancer Ther (2022)